Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl C Awh

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Ophthalmology|May 6, 2014
Author reply: To PMID 23972322Carl C Awh, Anne Marie Lane, Steven Hawken, et al.
Ophthalmology|August 27, 2013
CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degenerationCarl C Awh, Anne-Marie Lane, Steven Hawken, et al.
Ophthalmology and Therapy|June 1, 2026
Real-World Utilization and Initial Experience with Aflibercept-ayyh (PAVBLU<sup>®</sup>) for Retinal Disorders in United States Retina Practices: A Descriptive Retrospective AnalysisArgentina E Servin, Ian McFadden, Houri Esmaeilkhanian, et al.
Ophthalmology|June 5, 2004
Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degenerationSébastien Olivier, David R Chow, Kirk H Packo, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
SUSTAINED BIWEEKLY AFLIBERCEPT FOR REFRACTORY NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The Prospective TRISTAR StudyEric W Schneider, Mridul K Thomas, Franco M Recchia, et al.
Journal of Vitreoretinal Diseases|April 3, 2023
The Impact of COVID-19 on US and International Retina Specialists, Their Practices, and Their PatientsPaul Hahn, Jill F Blim, Kirk Packo, et al.
Current Opinion in Ophthalmology|March 19, 2019
Introduction to hypersonic vitrectomyKevin J Blinder, Carl C Awh, Asheesh Tewari, et al.
Journal of Vitreoretinal Diseases|April 3, 2023
Intravitreal Injection Therapy: Current Techniques and Supplemental ServicesLinda A Lam, Sonia Mehta, Eleonora M Lad, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
<i>CFH</i> and <i>ARMS2</i> genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementationDemetrios G Vavvas, Kent W Small, Carl C Awh, et al.
Ophthalmology|February 3, 2007
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degenerationDavid S Boyer, Andrew N Antoszyk, Carl C Awh, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Ophthalmology|May 6, 2014
Author reply: To PMID 23972322Carl C Awh, Anne Marie Lane, Steven Hawken, et al.
Ophthalmology|August 27, 2013
CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degenerationCarl C Awh, Anne-Marie Lane, Steven Hawken, et al.
Ophthalmology and Therapy|June 1, 2026
Real-World Utilization and Initial Experience with Aflibercept-ayyh (PAVBLU<sup>®</sup>) for Retinal Disorders in United States Retina Practices: A Descriptive Retrospective AnalysisArgentina E Servin, Ian McFadden, Houri Esmaeilkhanian, et al.
Ophthalmology|June 5, 2004
Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degenerationSébastien Olivier, David R Chow, Kirk H Packo, et al.
Retina (Philadelphia, Pa.)|February 2, 2023
SUSTAINED BIWEEKLY AFLIBERCEPT FOR REFRACTORY NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: The Prospective TRISTAR StudyEric W Schneider, Mridul K Thomas, Franco M Recchia, et al.
Journal of Vitreoretinal Diseases|April 3, 2023
The Impact of COVID-19 on US and International Retina Specialists, Their Practices, and Their PatientsPaul Hahn, Jill F Blim, Kirk Packo, et al.
Current Opinion in Ophthalmology|March 19, 2019
Introduction to hypersonic vitrectomyKevin J Blinder, Carl C Awh, Asheesh Tewari, et al.
Journal of Vitreoretinal Diseases|April 3, 2023
Intravitreal Injection Therapy: Current Techniques and Supplemental ServicesLinda A Lam, Sonia Mehta, Eleonora M Lad, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 10, 2018
<i>CFH</i> and <i>ARMS2</i> genetic risk determines progression to neovascular age-related macular degeneration after antioxidant and zinc supplementationDemetrios G Vavvas, Kent W Small, Carl C Awh, et al.
Ophthalmology|February 3, 2007
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degenerationDavid S Boyer, Andrew N Antoszyk, Carl C Awh, et al.
Pageof 4